Simplified registration for medicines using domestically produced APIs requires clear implementation mechanism – opinion

INTELLIGENCE SUMMARY

The simplification of the registration process for medicines produced from domestically sourced active pharmaceutical ingredients (APIs), as outlined in the government’s Action Plan, will serve as an incentive for the development of API production, but will require a clearly defined implementation mechanism, according to CEO of the Interchem pharmaceutical company Anatoliy Reder.